Cochlear LIMITED

Cochlear LIMITED is an international organization registered to receive awards from the U.S. federal government since May 25, 2012. As a foreign-owned, for-profit manufacturer of goods, Cochlear LIMITED specializes in the production of medical devices, particularly cochlear implants and other hearing solutions. The company's expertise lies in developing innovative technologies to address hearing loss and related disorders, contributing to advancements in auditory health and research. Cochlear LIMITED's involvement in federal contracts and grants demonstrates its commitment to supporting healthcare initiatives and scientific progress in the field of hearing technology.

While specific details about Cochlear LIMITED's past prime and sub federal contract awards are not provided in the given information, it can be inferred that the company's contracts likely involve the supply of cochlear implants, hearing devices, and related technologies to federal agencies and medical institutions. These contracts may include partnerships with research facilities, hospitals, and other healthcare providers to support the implementation and evaluation of their hearing solutions in various clinical settings. The nature of Cochlear LIMITED's work via contracts likely encompasses the manufacturing, delivery, and maintenance of advanced hearing devices, as well as providing technical support and training to healthcare professionals using their products.

Cochlear LIMITED has been involved in federal grant awards, both as a prime recipient and as a sub-awardee. The company's most recent federal grant award as a prime recipient was on May 15, 2013. More recently, Cochlear LIMITED has served as an industrial collaborator and sub-grantee on a project led by the University of Arkansas. This particular sub-award, identified as W81XWH1910839000002QPENZGH4J7D4, involves the development and testing of a neural interface system for an FDA-approved implantable FIU investigational device. Cochlear LIMITED's role in this project includes fabricating and sterilizing human-use implantable investigational devices, preparing sterilization reports, providing associated commercial-use external controller hardware, and offering guidance on firmware for controlling the implants. The company also supports the project by supplying non-human-use devices for surgical training. This collaboration demonstrates Cochlear LIMITED's involvement in cutting-edge research and development in the field of neural interfaces and auditory implant technology, contributing to advancements in medical science and patient care.